Eli Lilly and Novo Nordisk’s competition in weight-loss drugs has affected thousands of jobs between Charlotte and Raleigh.

This article was reviewed by Darragh O’Carroll, MD. Diabetes Medications for Weight Loss: What to Know Key takeaways: Some ...

Lupin Ltd (BOM:500257) reports robust financial performance with significant US market growth and strategic expansions in Europe and emerging markets.

Recently, new drugs - analogs of the gut hormone glucagon-like peptide-1 (GLP-1) have been added to the therapeutic arsenal, ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

Pfizer and Novo Nordisk are locked in a bidding war for biotech firm Metsera as the pharmaceutical giants seek to augment ...

While drugs like Wegovy, Ozempic and Mounjaro are hailed for regulating blood sugar and helping people lose weight, new ...

Metsera's lead pipeline asset is MET-097i, a GLP-1 receptor agonist designed for once-monthly injection. Novo's weight-loss drugs Wegovy and Eli Lilly's Zepbound and Mounjaro require weekly injections ...

A generic blood pressure drug called prazosin, made by Teva Pharmaceuticals, is being recalled by the Food and Drug ...

Voodoo Scientific has developed a process that, when applied to fiery hooch, results in a more sippable tipple.

Q2 2026 Earnings Call November 12, 2025 4:00 AM ESTCompany ParticipantsSam GhezelbashSimon Michel - CEO & Member of ...